As of 3:59pm ET
| +0.10 / +0.65%|
The 8 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 23.00, with a high estimate of 26.00 and a low estimate of 17.00. The median estimate represents a +48.39% increase from the last price of 15.50.
The current consensus among 8 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.